Israel MAPS Conference
As part of MAPS’ efforts to sponsor a pilot study in Israel into the use of MDMA-assisted psychotherapy in subjects with war and terrorism-related posttraumatic stress disorder (PTSD), MAPS is sponsoring a one-day conference in Israel on Thursday, March 24, 2005, in association with the Israeli Ministry of Health, the Israeli Anti-Drug Authority, and the Israeli Society of Addiction Medicine. MAPS is inviting all MAPS members and friends to attend and may also organize a 6-day tour of Israel, scheduled around the conference. If you are interested in attending, or would like more information, please contact Valerie Mojeiko, MAPS staff person, at valerie@maps.org.
Speakers at the conference include:
* Rick Doblin, Ph.D. President of MAPS
* Dr. Michael Mithoefer, MD. Principal Investigator, MAPS-sponsored MDMA/PTSD study
* Jose Carlos Bouso, Ph.D. candidate, Principal Investigator, proposed MAPS-sponsored MDMA/PTSD study in Spain
* June May Ruse, Ph.D., director of MAPS’ MDMA Treatment Manual Project
* Dr. Raphael Mechoulam, Hebrew University, Marijuana/PTSD Study to be conducted in Israel
* Dr. John Halpern, MD. (Harvard), Principal Investigator, MAPS-sponsored MDMA/Cancer Anxiety study
* Valerie Mojeiko, MAPS’ ibogaine outcome study
* Dr. Udi Bastiaans, ibogaine outcome study
